Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F-induced Contractions and Inflammatory Responses in Human Myometrium.

Kim SH, Riaposova L, Ahmed H, Pohl O, Chollet A, Gotteland JP, Hanyaloglu A, Bennett PR, Terzidou V.

Sci Rep. 2019 Apr 8;9(1):5792. doi: 10.1038/s41598-019-42181-2.

2.

Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone.

Pohl O, Marchand L, Gotteland JP, Coates S, Täubel J, Lorch U.

Br J Clin Pharmacol. 2019 Jul;85(7):1516-1527. doi: 10.1111/bcp.13925. Epub 2019 May 11.

PMID:
30891820
3.

Efficient Design of Integrated and Adaptively Interlinked Protocols for Early-Phase Drug Development Programs.

Coates S, Pohl O, Gotteland JP, Täubel J, Lorch U.

Ther Innov Regul Sci. 2019 Jan 27:2168479018821087. doi: 10.1177/2168479018821087. [Epub ahead of print]

PMID:
30686046
4.

OBE022, an Oral and Selective Prostaglandin F2α Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor.

Pohl O, Chollet A, Kim SH, Riaposova L, Spézia F, Gervais F, Guillaume P, Lluel P, Méen M, Lemaux F, Terzidou V, Bennett PR, Gotteland JP.

J Pharmacol Exp Ther. 2018 Aug;366(2):349-364. doi: 10.1124/jpet.118.247668. Epub 2018 May 18.

PMID:
29777040
5.

Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal women.

Pohl O, Marchand L, Gotteland JP, Coates S, Täubel J, Lorch U.

Br J Clin Pharmacol. 2018 Aug;84(8):1839-1855. doi: 10.1111/bcp.13622. Epub 2018 Jun 5.

6.

Confirmation of the Cardiac Safety of PGF Receptor Antagonist OBE022 in a First-in-Human Study in Healthy Subjects, Using Intensive ECG Assessments.

Täubel J, Lorch U, Coates S, Fernandes S, Foley P, Ferber G, Gotteland JP, Pohl O.

Clin Pharmacol Drug Dev. 2018 Nov;7(8):889-900. doi: 10.1002/cpdd.447. Epub 2018 Feb 28.

7.

Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109.

Pohl O, Marchand L, Fawkes N, Gotteland JP, Loumaye E.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):497-504. doi: 10.1210/jc.2017-01875.

PMID:
29216361
8.

Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor-Mediated Signaling in Human Amnion and Myometrium.

Kim SH, Pohl O, Chollet A, Gotteland JP, Fairhurst AD, Bennett PR, Terzidou V.

Mol Pharmacol. 2017 Apr;91(4):403-415. doi: 10.1124/mol.116.106013. Epub 2017 Feb 10.

9.

Inferring the Chemotactic Strategy of P. putida and E. coli Using Modified Kramers-Moyal Coefficients.

Pohl O, Hintsche M, Alirezaeizanjani Z, Seyrich M, Beta C, Stark H.

PLoS Comput Biol. 2017 Jan 23;13(1):e1005329. doi: 10.1371/journal.pcbi.1005329. eCollection 2017 Jan.

10.

Active Brownian particles and run-and-tumble particles separate inside a maze.

Khatami M, Wolff K, Pohl O, Ejtehadi MR, Stark H.

Sci Rep. 2016 Nov 23;6:37670. doi: 10.1038/srep37670.

11.

Effects of the Oral Oxytocin Receptor Antagonist Tocolytic OBE001 on Reproduction in Rats.

Pohl O, Perks D, Rhodes J, Comotto L, Baldrick P, Chollet A.

Reprod Sci. 2016 Apr;23(4):439-47. doi: 10.1177/1933719115607979. Epub 2015 Sep 23.

PMID:
26399985
12.

Self-phoretic active particles interacting by diffusiophoresis: A numerical study of the collapsed state and dynamic clustering.

Pohl O, Stark H.

Eur Phys J E Soft Matter. 2015 Aug;38(8):93. doi: 10.1140/epje/i2015-15093-4. Epub 2015 Aug 31.

PMID:
26314260
13.

Emergence of collective changes in travel direction of starling flocks from individual birds' fluctuations.

Attanasi A, Cavagna A, Del Castello L, Giardina I, Jelic A, Melillo S, Parisi L, Pohl O, Shen E, Viale M.

J R Soc Interface. 2015 Jul 6;12(108):20150319.

14.

Pharmacokinetic interactions of OBE001 and betamethasone in healthy female volunteers.

Pohl O, Homery MC, Lemaux F, Patat A, Chollet A.

J Clin Pharm Ther. 2015 Jun;40(3):328-32. doi: 10.1111/jcpt.12258. Epub 2015 Feb 26.

PMID:
25899007
15.

Finite-size scaling as a way to probe near-criticality in natural swarms.

Attanasi A, Cavagna A, Del Castello L, Giardina I, Melillo S, Parisi L, Pohl O, Rossaro B, Shen E, Silvestri E, Viale M.

Phys Rev Lett. 2014 Dec 5;113(23):238102. Epub 2014 Dec 1.

16.

Information transfer and behavioural inertia in starling flocks.

Attanasi A, Cavagna A, Del Castello L, Giardina I, Grigera TS, Jelić A, Melillo S, Parisi L, Pohl O, Shen E, Viale M.

Nat Phys. 2014 Sep 1;10(9):615-698.

17.

The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroids.

Pohl O, Zobrist RH, Gotteland JP.

Reprod Sci. 2015 Apr;22(4):476-83. doi: 10.1177/1933719114549850. Epub 2014 Sep 16. Review.

18.

Collective behaviour without collective order in wild swarms of midges.

Attanasi A, Cavagna A, Del Castello L, Giardina I, Melillo S, Parisi L, Pohl O, Rossaro B, Shen E, Silvestri E, Viale M.

PLoS Comput Biol. 2014 Jul 24;10(7):e1003697. doi: 10.1371/journal.pcbi.1003697. eCollection 2014 Jul.

19.

Dynamic clustering and chemotactic collapse of self-phoretic active particles.

Pohl O, Stark H.

Phys Rev Lett. 2014 Jun 13;112(23):238303. Epub 2014 Jun 10.

PMID:
24972234
20.

Social interactions dominate speed control in poising natural flocks near criticality.

Bialek W, Cavagna A, Giardina I, Mora T, Pohl O, Silvestri E, Viale M, Walczak AM.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7212-7. doi: 10.1073/pnas.1324045111. Epub 2014 May 1.

21.

Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age.

Pohl O, Bestel E, Gotteland JP.

Reprod Sci. 2014 Oct;21(10):1256-65. doi: 10.1177/1933719114522526. Epub 2014 Mar 6.

PMID:
24604234
22.

Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate.

Pohl O, Osterloh I, Gotteland JP.

J Clin Pharm Ther. 2013 Dec;38(6):512-7. doi: 10.1111/jcpt.12098. Epub 2013 Sep 16.

PMID:
24102384
23.

Carcinogenicity and chronic rodent toxicity of the selective progesterone receptor modulator ulipristal acetate.

Pohl O, Harvey PW, McKeag S, Boley SE, Gotteland JP.

Curr Drug Saf. 2013 Apr;8(2):77-97.

PMID:
23656453
24.

Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day.

Pohl O, Osterloh I, Gotteland JP.

J Clin Pharm Ther. 2013 Aug;38(4):314-20. doi: 10.1111/jcpt.12065. Epub 2013 Apr 3.

PMID:
23550906
25.

A 39-week oral toxicity study of ulipristal acetate in cynomolgus monkeys.

Pohl O, Williams AR, Bergeron C, Gotteland JP.

Regul Toxicol Pharmacol. 2013 Jun;66(1):6-12. doi: 10.1016/j.yrtph.2013.02.013. Epub 2013 Mar 7.

PMID:
23474274
26.

Changes in gastric pH and in pharmacokinetics of ulipristal acetate - a drug-drug interaction study using the proton pump inhibitor esomeprazole.

Pohl O, Osterloh I, Lecomte V, Gotteland JP.

Int J Clin Pharmacol Ther. 2013 Jan;51(1):26-33. doi: 10.5414/CP201789.

PMID:
23110788
27.

Retrospective detection of a subclinical hepatitis A virus (HAV) epidemic affecting juvenile cohorts of the Hungarian population.

Pohl O, Brojnás J, Rusvai E, Ordög K, Siska I, Faludi G, Kapusinszky B, Csohán A, Lendvai K, Lengyel A, Mezey I, Berencsi G.

FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):85-91.

28.

Disease dustup.

Pohl O.

Sci Am. 2003 Jul;289(1):18, 20. No abstract available.

PMID:
12840937
29.
30.

Age-related memory decline and longevity under treatment with selegiline.

Stoll S, Hafner U, Pohl O, Müller WE.

Life Sci. 1994;55(25-26):2155-63. Review.

PMID:
7997074
31.

[Respiratory and enteric rotavirus infections in a pediatric unit].

Lakos A, Koller M, Szarka E, Csik M, Vandra K, Pohl O.

Orv Hetil. 1985 Dec 1;126(48):2969-72. Hungarian. No abstract available.

PMID:
4069693
32.

HBsAg-like structures in immunosuppressed mice inoculated with human hepatitis B virus.

Schaff Z, Pohl O, Bencsáth M, Brojnás J, Lapis K, Kopper L, Hollós I.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1982 Aug;40(2):249-61.

PMID:
6127839
33.

[Serodiagnostic problems of Non-A, Non-B viral hepatitis].

Hollós I, László B, Brojnás J, Pohl O, Keszei N, Szalka A, Tolnai G, Sántha M, Schaff Z, Szabados T.

Orv Hetil. 1981 Oct 25;122(43):2639-45. Hungarian. No abstract available.

PMID:
6798531
34.

[Distribution of hepatitis B surface antigen subtypes in the serum of hepatitis patients and healthy blood donors].

Pohl O, Novák E, Zgyerka S, Hollós I.

Orv Hetil. 1980 Jul 27;121(30):1811-7. Hungarian. No abstract available.

PMID:
7454292
35.

[Concordant schizophrenic psychoses in enzygotic twin brothers. (On the problem of concordance and discordance in schizophrenic twins)].

Pohl O, Haits G.

Psychiatr Neurol Med Psychol (Leipz). 1969 Jan;21(1):28-32. German. No abstract available.

PMID:
5799819
36.

Hypomanic psychosis alternating with periodical hypersonmia.

Pohl O, Haits G.

Psychiatr Clin (Basel). 1968;1(2):120-4. No abstract available.

PMID:
5680858
37.

[Psychoses in chronic subdural hematomas].

Pohl O, Haits G.

Dtsch Gesundheitsw. 1967 Sep 14;22(37):1749-51. German. No abstract available.

PMID:
5602172
38.

[Data on the pathology of neural complications following lumbal anesthesia].

Pohl O.

Orv Hetil. 1967 Mar 19;108(12):565-7. Hungarian. No abstract available.

PMID:
6042914
39.

[A contribution on the pathology of symptomatic narcolepsy].

Pohl O.

Dtsch Z Nervenheilkd. 1966 Sep 14;189(3):211-7. German. No abstract available.

PMID:
5983395
40.

[On the corticosteroid-depression].

Pohl O, Haits G.

Nervenarzt. 1966 Sep;37(9):406-10. German. No abstract available.

PMID:
4293058
41.

[Concerning the problem of mnemic negativism. An anthropological-psychiatric contribution].

Pohl O, Haits G.

Nervenarzt. 1966 Mar;37(3):96-8. German. No abstract available.

PMID:
5966481
42.

[On the pathology of neural complications of lumbar anesthesia].

Pohl O.

Arch Psychiatr Nervenkr (1970). 1966;208(3):299-308. German. No abstract available.

PMID:
5965091
43.

[On a peculiar form of post-traumatic confabulations].

Pohl O, Haits G.

Psychiatr Neurol (Basel). 1966;151(5):291-302. German. No abstract available.

PMID:
5959050
44.

[An expansive-productive confabulatory disease picture with a peculiar course observed following a previous skull injury].

Pohl O, Haits G.

Nervenarzt. 1965 Dec;36(12):527-9. German. No abstract available.

PMID:
5873656
45.

[Data on clinical and pathological aspects in DDT intoxication].

FORNADI F, POHL O, SZEGEDY L.

Ideggyogy Sz. 1961 Nov;14:313-23. Hungarian. No abstract available.

PMID:
13894092

Supplemental Content

Support Center